To screen ETFs by asset class, performance, yield and more, check out the
View as an RSS Feed
View nwcoast's Comments
Is Cell Therapeutics Turning Over A New Leaf In 2014?
Interesting article and very nice pop on this one! Perhaps even a break out!
Cautiously, VERY cautiously optimistic on this one... With such a long history of dilutions and reverse stock splits, this company has no shortage of bitter investors that have been burned on the way down and flogged. If most of those holders have been shaken out, and we've built a long enough base of new capital, this 'fresh start' and significant news, might just be a fresh start! I hope so!
Jan 6, 2014. 04:32 PM
Link to Comment
Compelling Phase II Data De-risks Advaxis
You bring up a very good question and one I too have struggled with stills999. I should think if the studies are well constructed and executed, the results published, and recognized as accurate, then there would indeed be some serious attention at hand! The road for various cancer vaccines has been riddled with near misses and false hopes for a quite some time..Perhaps the investment community is still stinging from their past burns on some of their prior attempts and spooked. Perhaps this whole thing is flying entirely under the radar and not widely published and recognized for what appears to be some faIrly significant positive results! Or, perhaps the study is not being taken seriously because of the patient selection model, or any number of other variables.... It may be a great sampling! Perhaps being conducted in India is a factor? I'm not sure and like you, am curious...
I know that there are other much larger Pharma power houses funding studies on targeted head and neck cancers. So Advaxis is not without competition....
Very good sign is that there has been significant insider buying over the past couple of months!
I'm hoping, and cautiously optimistic that this may indeed be a diamond in the rough, undiscovered, and under valued... And, with a market cap of micro-mini cap proportions, could be in for a nice run, if indeed these products are recognized, and brought to light in the media and investment community.
Not to mention the amazing benefits to those suffering currently- who might benefit, and those that might be spared future suffering if indeed their efforts result in clinical and commercial success!
The canine sarcoma quest is promising as well.... I'm hopeful this yields positive outcomes as there is little effort being done elsewhere on this front.
There's a lot of risk in this little stock though.....
Like many other small bio techs, all it would take would be a fatality or two during clinical trials to let the air out of their balloon.......
For the time being though, it looks good to me, I'm buying more, and hanging on for the ride.
Lot's of upside potential IMO! But, not betting the entire house here....
Balance of risk helps me sleep better at night...
Would love to hear what others think...
Very little chatter on this stock elsewhere- which is a very good thing from my perspective at this point in time!
Nov 27, 2013. 08:24 AM
Link to Comment
Xignite quote data
© 2015 Seeking Alpha